Ampullary Cancers Harbor ELF3 Tumor Suppressor Gene Mutations and Exhibit Frequent WNT Dysregulation.
about
Where does chemotherapy stands in the treatment of ampullary carcinoma? A review of literatureGenomic and proteomic characterization of ARID1A chromatin remodeller in ampullary tumors.PD-L1 overexpression in ampulla of Vater carcinoma and its pre-invasive lesions.Emerging molecular therapeutic targets for cholangiocarcinoma.EZH2 in Cancer Progression and Potential Application in Cancer Therapy: A Friend or Foe?Liver Cancer: Molecular Characterization, Clonal Evolution and Cancer Stem Cells.Cholangiocarcinoma - evolving concepts and therapeutic strategies.Ampullary cancer of intestinal origin and duodenal cancer - A logical clinical and therapeutic subgroup in periampullary cancer.Pan-cancer molecular classes transcending tumor lineage across 32 cancer types, multiple data platforms, and over 10,000 cases.Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas.Phase II study of everolimus (RAD001) monotherapy as first-line treatment in advanced biliary tract cancer with biomarker exploration: the RADiChol Study.Exome-wide somatic mutation characterization of small bowel adenocarcinoma.Pancreatic Cancer: Molecular Characterization, Clonal Evolution and Cancer Stem Cells.Current approaches to immunotherapy in noncolorectal gastrointestinal malignanciesELF3, ELF5, EHF and SPDEF Transcription Factors in Tissue Homeostasis and Cancer
P2860
Q28077772-4DC76D10-7A75-4027-AF58-9B8298FF7CCFQ37743503-445935D5-4A28-4977-B6DA-59A8AF7A2109Q38787346-17B0C06F-195D-4276-A977-15F866345246Q39227356-19E2BAEC-8467-42ED-B772-C76861E03DAAQ39340502-800F13E5-B89E-4CAA-A8B5-BC367E1D2AB9Q41670848-80D06CEA-5596-4AD3-952D-5285F1D5F449Q46087686-9FA6B289-52B7-4EFD-ACD1-9BB8BD271672Q47124313-577FE8CD-8B7D-45B2-8251-663FCC9E9AD9Q50027342-0C0D33D4-8A04-4FDC-B57B-831AEBE35EDBQ52607320-3A4F4E8A-0A11-4D77-AFFA-67517D0A40ADQ52661828-411D9CD1-58F5-4F67-8B78-D4EF6D935379Q52664402-1F853338-6105-4405-9043-8A20F74F9705Q55104265-09883FCB-7CFF-416A-8A14-ED67C3895791Q58594584-A43B91AA-90F2-4AE4-A9AA-C3ACD7952D5FQ58696663-5D69A52B-3CB9-4610-9405-120432E41EA4
P2860
Ampullary Cancers Harbor ELF3 Tumor Suppressor Gene Mutations and Exhibit Frequent WNT Dysregulation.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 January 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Ampullary Cancers Harbor ELF3 ...... it Frequent WNT Dysregulation.
@en
Ampullary Cancers Harbor ELF3 ...... it Frequent WNT Dysregulation.
@nl
type
label
Ampullary Cancers Harbor ELF3 ...... it Frequent WNT Dysregulation.
@en
Ampullary Cancers Harbor ELF3 ...... it Frequent WNT Dysregulation.
@nl
prefLabel
Ampullary Cancers Harbor ELF3 ...... it Frequent WNT Dysregulation.
@en
Ampullary Cancers Harbor ELF3 ...... it Frequent WNT Dysregulation.
@nl
P2093
P2860
P50
P1433
P1476
Ampullary Cancers Harbor ELF3 ...... bit Frequent WNT Dysregulation
@en
P2093
Amber L Johns
Amy McElhany
Anthony J Gill
Australian Pancreatic Cancer Genome Initiative
Chad J Creighton
Charupong Saengboonmee
Daniela Aust
David A Wheeler
David K Chang
Donna M Muzny
P2860
P304
P356
10.1016/J.CELREP.2015.12.005
P50
P577
2016-01-21T00:00:00Z